Monashee Investment Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,267	Closed	-$659K	–	202
2018 Q1	$659K	Buy	+6,267	New	+$659K	0.18%	89